{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:48Z","timestamp":1793157948846,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["COV0170"],"award-info":[{"award-number":["COV0170"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005370","name":"Gates Cambridge Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacig.2023.100091","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T13:50:22Z","timestamp":1678888222000},"page":"100091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2099-982X","authenticated-orcid":false,"given":"Ernest T.","family":"Aguinam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angalee","family":"Nadesalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Paloniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gronlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Gronlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Carnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Castillo-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Blacklaws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2702-1621","authenticated-orcid":false,"given":"Jonathan L.","family":"Heeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3838-3900","authenticated-orcid":false,"given":"Helen","family":"Baxendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2023.100091_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7104e1","article-title":"COVID-19 cases and hospitalizations by COVID-19 vaccination status and previous COVID-19 diagnosis\u2014California and New York, May-November 2021","volume":"71","author":"Le\u00f3n","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacig.2023.100091_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"10269","key":"10.1016\/j.jacig.2023.100091_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100091_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s15010-021-01664-z","article-title":"Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?","volume":"50","author":"Hamady","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.jacig.2023.100091_bib5","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.3346\/jkms.2021.36.e311","article-title":"Comparison of antibody response elicited by ChAdOx1 and BNT162b2 COVID-19 vaccine","volume":"36","author":"Kang","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jacig.2023.100091_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jacig.2023.100091_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4509","article-title":"Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2","volume":"6","author":"Israelow","year":"2021","journal-title":"Sci Immunol"},{"issue":"7847","key":"10.1016\/j.jacig.2023.100091_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jacig.2023.100091_bib9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jacig.2023.100091_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jacig.2023.100091_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102185","article-title":"Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain","volume":"42","author":"Montero-Escribano","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jacig.2023.100091_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102120","article-title":"COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?","volume":"42","author":"Novi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jacig.2023.100091_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci Immunol"},{"issue":"7833","key":"10.1016\/j.jacig.2023.100091_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2\u2013reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jacig.2023.100091_bib16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jacig.2023.100091_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fimmu.2017.00319","article-title":"The other function: class II\u2013restricted antigen presentation by B cells","volume":"8","author":"Adler","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: an international study","volume":"147","author":"Meyts","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience","volume":"147","author":"Shields","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103705","article-title":"Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial","volume":"74","author":"Bergman","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jacig.2023.100091_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10875-022-01231-7","article-title":"SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study","volume":"42","author":"Shields","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib22","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1016\/S2666-5247(21)00157-9","article-title":"Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK","volume":"2","author":"Nadesalingam","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jacig.2023.100091_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748291","article-title":"Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases","volume":"12","author":"Castillo-Olivares","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/mps1010008","article-title":"Pseudotype neutralization assays: from laboratory bench to data analysis","volume":"1","author":"Ferrara","year":"2018","journal-title":"Methods Protoc"},{"key":"10.1016\/j.jacig.2023.100091_bib25","unstructured":"Di Genova C, Sampson A, Scott S, Cantoni D, Mayora-Neto M, Bentley E, et\u00a0al. Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypes. Figshare, December 30, 2020. Available at: https:\/\/figshare.com\/articles\/preprint\/Production_titration_neutralisation_and_storage_of_SARS-CoV-2_lentiviral_pseudotypes\/13502580\/2."},{"key":"10.1016\/j.jacig.2023.100091_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00259-020-04735-9","article-title":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","volume":"47","author":"Xu","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6572","key":"10.1016\/j.jacig.2023.100091_bib27","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jacig.2023.100091_bib28","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1158\/1078-0432.CCR-21-4413","article-title":"An autologous dendritic cell vaccine promotes anticancer immunity in patients with ovarian cancer with low mutational burden and cold tumors","volume":"28","author":"Fucikova","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jacig.2023.100091_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2023.100091_bib30","series-title":"StatPearls. Treasure Island (FL)","article-title":"IgA deficiency","author":"Rawla","year":"2022"},{"key":"10.1016\/j.jacig.2023.100091_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101018","article-title":"Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals","volume":"38","author":"Demonbreun","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jacig.2023.100091_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.07.008","article-title":"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations","volume":"54","author":"Muecksch","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jacig.2023.100091_bib33","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/QAD.0b013e32834b348e","article-title":"Multiple HIV-1\u2013specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection","volume":"25","author":"Yates","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jacig.2023.100091_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncomms1608","article-title":"Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential","volume":"2","author":"Stapleton","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacig.2023.100091_bib35","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2021-220626","article-title":"Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression","volume":"80","author":"Prendecki","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacig.2023.100091_bib36","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/S2665-9913(22)00027-3","article-title":"COVID-19 vaccine\u2013induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1","volume":"4","author":"Saleem","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jacig.2023.100091_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12979-021-00246-9","article-title":"Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people","volume":"18","author":"Parry","year":"2021","journal-title":"Immun Ageing"},{"key":"10.1016\/j.jacig.2023.100091_bib38","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2666-7568(21)00169-0","article-title":"Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis","volume":"2","author":"Parry","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jacig.2023.100091_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jacig.2023.100091_bib40","first-page":"1","article-title":"The activation of bystander CD8+ T cells and their roles in viral infection","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jacig.2023.100091_bib41","article-title":"Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients","volume":"11","author":"Westmeier","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jacig.2023.100091_bib42","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous COVID-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100091_bib43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/jmv.27463","article-title":"COVID-19 vaccines mix-and-match: the concept, the efficacy and the doubts","volume":"94","author":"Rashedi","year":"2022","journal-title":"J Med Virol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:19:47Z","timestamp":1762647587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829323000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2772829323000164"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100091","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100091"}}